PF4通过STAT1促进小鼠免疫性血小板减少症中CXCR3+ Tfh1细胞分化
该研究在小鼠免疫性血小板减少症(ITP)模型中检测到血清和脾脏PF4表达显著上调及CXCR3+ I型滤泡辅助性T(Tfh1)细胞扩增;体外实验显示重组PF4蛋白联合IL-12通过STAT1通路协同促进naïve CD4+ T细胞向Tfh1细胞分化,提示PF4在激活Tfh1细胞分化扩增并最终促进ITP发病中发挥作用。
要点
- ITP小鼠血清和脾脏PF4表达显著上调,同时CXCR3+ Tfh1细胞扩增。
- 重组PF4蛋白联合IL-12通过STAT1通路协同促进naïve CD4+ T细胞向Tfh1细胞分化。
- PF4可激活Tfh1细胞分化与扩增,并最终促进ITP发病。
核心结论
- 研究鉴定出PF4在激活Tfh1细胞分化与扩增并最终促进ITP发病中的作用。
研究设计与样本
- 研究类型为小鼠ITP模型结合体外细胞实验,检测ITP小鼠血清和脾脏PF4表达及CXCR3+ Tfh1细胞扩增,并在体外用重组PF4蛋白联合IL-12处理naïve CD4+ T细胞。
主要发现
- ITP小鼠血清和脾脏中PF4表达显著上调,并伴有CXCR3+ Tfh1细胞扩增。
- 体外给予重组PF4蛋白联合IL-12可通过STAT1通路协同促进naïve CD4+ T细胞向Tfh1细胞分化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by low platelet counts. The mechanism of ITP is complex and remains incompletely understood, but loss of self-tolerance and immune cell dysfunction are associated with this disease. Platelet factor 4 (PF4) is released by activated platelets and has several other biological functions, including leucocyte activation and differentiation. In this study, we detected significant upregulation of PF4 expression in the serum and spleen of ITP mice and the expansion of CXCR3+ type I follicular helper T (Tfh1) cells. An in vitro study revealed that the administration of recombinant PF4 protein in combination with IL-12 synergistically promoted the differentiation of naïve CD4+ T cells into Tfh1 cells through the STAT1 pathway. In this study, we identified the role of PF4 in activating Tfh1 cell differentiation and expansion and eventually promoting the pathogenesis of ITP.
引用
- Hai L, Zheng Y, Yang Z, et al. PF4 promotes CXCR3+ Tfh1 cell differentiation through STAT1 in mouse immune thrombocytopenia. Br J Haematol. 2025. PMID: 40235276. doi:10.1111/bjh.20090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。